Condition
Diagnostic Test
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results80% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06693050CompletedPrimary
AQT90 FLEX NTproBNP2 Test Kit Method Comparison Study
NCT06078956Not ApplicableCompletedPrimary
ABL90 Flex Plus Method Comparison Study_Adults
NCT05801341Not ApplicableTerminated
Inpatient COVID-19 Lollipop Study
NCT05804487CompletedPrimary
ABL90 FLEX PLUS Clinical Precision Study for 15 Parameters in Adult Whole Blood
NCT05769244Not ApplicableCompletedPrimary
Near Infrared Spectroscopy and Testicular Torsion in Children
Showing all 5 trials